Investigating the link between hypertension, diabetes, cancer treatments, and the risk of Alzheimer's disease.
The Risk of Developing Alzheimer’s Disease and Related Dementias Associated with Hypertension, Diabetes, and Drug Therapies for Cancer: Up to 30-year Follow-up for Older Medicare Beneficiaries
This study is looking at how having high blood pressure, diabetes, and certain cancer treatments might affect the chances of developing Alzheimer's and other types of dementia in older adults, using Medicare data to see if some medications could help protect against these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10771210 on NIH RePORTER |
What this research studies
This research examines how conditions like hypertension and diabetes, along with drug therapies for cancer, may influence the risk of developing Alzheimer's disease and related dementias over a long period. By utilizing Medicare's extensive database, the study aims to track older adults' health outcomes and identify potential protective effects of certain medications. The approach involves analyzing data from a large cohort of older Medicare beneficiaries to assess the combined impact of these health factors on cognitive decline. This could help clarify the relationship between chronic conditions and dementia risk.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and above who have a history of hypertension, diabetes, or have undergone cancer treatment.
Not a fit: Patients who are younger than 65 or do not have any of the specified health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing Alzheimer's disease and related dementias in older adults.
How similar studies have performed: Previous research has shown promising results regarding the impact of blood pressure control on cognitive impairment, suggesting that this study's approach could yield valuable insights.
Where this research is happening
Houston, United States
- University of Texas Hlth Sci Ctr Houston — Houston, United States (Active)
Researchers
- Principal investigator: Du, Xianglin — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Du, Xianglin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.